DU‐145 prostate cancer cells showed an extraordinary 40‐fold increase in sensitivity to c‐Myc‐i7 compared to 10058‐F4, with c‐Myc‐i10 also demonstrating significant improvements. Here, MYC is linked to prostate cancer.